Purchase Order 75F40118P20351
Award Date 9/7/18
Potential Completion Date 9/16/21
Potential Value $93K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of nuclear magnetic resonance (NMR) equipment and services. The contract has a ceiling value of $1,334,738.00 and a period of performance ending on July 31, 2017. The contract was awarded on a full and open competition basis, with no set-aside designation. Bruker Biospin Corp is a manufacturer of advanced...
- The U.S. Food and Drug Administration (FDA) awarded a $195,933.11 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, to acquire a comprehensive service agreement from the original equipment manufacturer (OEM) Bruker. The agreement includes preventive maintenance with two (2) helium refills per year, as well as any repairs and support for a Bruker Avance III HD 600 instrument. The award has an ultimate completion date of August 31, 2027. Bruker...
- The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the procurement of a 400MHz NMR spectrometer food screening system, under solicitation FDA-RFQ-CFSAN-2024-121654. The total ceiling value of the contract is $359,990.00, with a completion date of July 4, 2025. This award is not associated with a set-aside program. Bruker Biospin Corp is a manufacturer of scientific instruments and has a...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
- This firm-fixed-price purchase order contract, awarded by the National Cancer Institute (NCI) to Bruker Biospin Corp, is valued at $369,168.00 and has an ultimate completion date of September 21, 2025. The contract is for the maintenance and preventive maintenance of a government-owned 700 MHz nuclear magnetic resonance (NMR) spectrometer console. This contract does not utilize any set-aside designations. Bruker Biospin Corp is a subsidiary of Bruker Scientific LLC, a prominent manufacturer of...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a subsidiary of Bruker Corporation, a $110,097.30 firm-fixed-price purchase order to provide an automatic sample changer and compatible probe for a Bruker 400 MHz nuclear magnetic resonance (NMR) spectrometer. The award has an August 17, 2024 completion date and was made on September 16, 2022. Bruker Biospin Corp is a for-profit manufacturer of scientific instruments and equipment. The company...
- This federal contract award to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, is for a maintenance agreement on a specialized scientific instrumentation package. The award, valued at $180,527.72, covers a LABSCAPE complete system including a nuclear magnetic resonance (NMR) console, cryoplatform, and multiple cryogenic probes. The contract provides for two helium fill-ups per year on this equipment through June 16, 2025. The contract was awarded by the Food and Drug Administration...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $732,711.84 firm fixed price purchase order to Bruker Biospin Corp. of Billerica, Massachusetts for an NMR CONSOLE AVANCE NEO 500 MHZ. The contract has a period of performance starting on September 18, 2022 through September 17, 2023 for the place of performance in Billerica, MA. Bruker Biospin Corp. will provide an NMR CONSOLE AVANCE NEO 500 MHZ as the prime contractor for the HHS FDA under this...